Histogen Inc. Banner Image

Histogen Inc.

  • Ticker HSTO
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Histogen Inc. Logo Image
  • 11-50 Employees
  • Based in San Diego, California
Histogen Inc. is a clinical-stage therapeutics company focused on developing potential first-in class clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that protect the body’s natural process to restore immune function. Their pipeline includes emricasan, CTS-2090 and other proprietary caspase inhibitors. They believe that emricasan has the potential toMore treat infections in a different way; by protecting the competence of the body’s immune system thereby restoring the body’s natural process to combat invading organisms. By focusing on optimizing the immune response, they believe that emricasan can be a viable option for physicians to treat and cure certain infectious diseases without the risk of generating resistance. CTS-2090 and other proprietary selective small molecule inhibitors of caspase-1 are designed for the treatment of certain inflammatory diseases.
Histogen Inc.

Most Recent Annual Report

Histogen Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Histogen Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!